학술논문

Safety of Adjuvant Pembrolizumab (pembro) in a Pooled Analysis of Phase 3 Clinical Trials in Melanoma, Non-Small Cell Lung Cancer (NSCLC), and Renal Cell Carcinoma
Document Type
Journal
Source
ANNALS OF SURGICAL ONCOLOGY; MAR 2023, 30 SUPPL 1, pS187-pS187, 1p. Supplement: 1
Subject
Language
English
ISSN
15344681